US FDA spying on device staff unlawful, claim lawmakers
This article was originally published in Clinica
Executive Summary
The US FDA may have acted unlawfully when it set up a highly-invasive electronic surveillance program to monitor employees who contacted Congress and the media with concerns about the agency’s medical device approval process, according to a joint report by two high-level lawmakers.